{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coronavirus", "Covid-19", "Repurposed drugs", "SARS-CoV-2", "Virus-host protein interactions"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33639193", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "06"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ejphar.2021.173977", "S0014-2999(21)00130-8"], "Journal": {"ISSN": "1879-0712", "JournalIssue": {"Volume": "898", "PubDate": {"Year": "2021", "Month": "May", "Day": "05"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Brief review on repurposed drugs and vaccines for possible treatment of COVID-19.", "Pagination": {"StartPage": "173977", "MedlinePgn": "173977"}, "Abstract": {"AbstractText": ["Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the pandemic coronavirus disease 2019 (Covid-19) has claimed more than a million lives. Various in silico, in vitro, and in vivo studies are being conducted to understand the effect of SARS-CoV-2 on the cellular metabolism of humans and the various drugs and drug-targets that may be used. In this review, we discuss protein-protein interactions (PPIs) between viral and human proteins as well as viral targets like proteases. We try to understand the molecular mechanism of various repurposed antiviral drugs against SARS-CoV-2, their combination therapies, drug dosage regimens, and their adverse effects along with possible alternatives like non-toxic antiviral phytochemicals. Ultimately, randomized controlled trials are needed to identify which of these compounds has the required balance of efficacy and safety. We also focus on the recent advancements in diagnostic methods and vaccine candidates developed around the world to fight against Covid-19."], "CopyrightInformation": "Copyright \u00a9 2021 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India."}], "LastName": "De", "ForeName": "Priyasha", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India."}], "LastName": "Chakraborty", "ForeName": "Ishita", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Medicine, Ulm University, Ulm, Germany."}], "LastName": "Karna", "ForeName": "Bhargavi", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biophysics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India. Electronic address: nirmaluva@gmail.com."}], "LastName": "Mazumder", "ForeName": "Nirmal", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "COVID-19 Vaccines"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["diagnosis", "prevention & control"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "COVID-19 Testing"}, {"QualifierName": [], "DescriptorName": "COVID-19 Vaccines"}, {"QualifierName": [], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["immunology"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbott T.R., Dhamdhere G., Liu Y., Lin X., Goudy L., Zeng L., Chemparathy A., Chmura S., Heaton N.S., Debs R., Pande T. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell. 2020;181:865\u2013876. doi: 10.1016/2Fj.cell.2020.04.020.", "ArticleIdList": ["10.1016/2Fj.cell.2020.04.020", "PMC7189862", "32353252"]}, {"Citation": "Adedeji A.O., Severson W., Jonsson C., Singh K., Weiss S.R., Sarafianos S.G. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J. Virol. 2013;87:8017\u20138028. doi: 10.1128/JVI.00998-13.", "ArticleIdList": ["10.1128/JVI.00998-13", "PMC3700180", "23678171"]}, {"Citation": "Adedeji A.O., Singh K., Kassim A., Coleman C.M., Elliott R., Weiss S.R., Frieman M.B., Sarafianos S.G. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob. Agents Chemother. 2014;58:4894\u20134898. doi: 10.1128/AAC.02994-14.", "ArticleIdList": ["10.1128/AAC.02994-14", "PMC4136041", "24841268"]}, {"Citation": "Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763\u20131767. doi: 10.1126/science.1085658.", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450\u2013452. doi: 10.1038/s41591-020-0820-9.", "ArticleIdList": ["10.1038/s41591-020-0820-9", "PMC7095063", "32284615"]}, {"Citation": "Arshad S., Kilgore P., Chaudhry Z.S., Jacobsen G., Wang D.D., Huitsing K., Brar I., Alangaden G.J., Ramesh M.S., McKinnon J.E., O'Neill W. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int. J. Infect. Dis. 2020;97:396\u2013403. doi: 10.1038/s41467-020-17189-2.", "ArticleIdList": ["10.1038/s41467-020-17189-2", "PMC7330574", "32623082"]}, {"Citation": "Astuti I. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab. Syndr. 2020;14:407\u2013412. doi: 10.1016/j.dsx.2020.04.020.", "ArticleIdList": ["10.1016/j.dsx.2020.04.020", "PMC7165108", "32335367"]}, {"Citation": "B\u00e1ez-Santos Y.M., John S.E.S., Mesecar A.D. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antivir. Res. 2015;115:21\u201338. doi: 10.1016/j.antiviral.2014.12.015.", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Barnes P.J. Role of HDAC2 in the pathophysiology of COPD. Annu. Rev. Physiol. 2009;71:451\u2013464. doi: 10.1146/annurev.physiol.010908.163257.", "ArticleIdList": ["10.1146/annurev.physiol.010908.163257", "18817512"]}, {"Citation": "Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., Hohmann E., Chu H.Y., Luetkemeyer A., Kline S., de Castilla D.L. Remdesivir for the treatment of Covid-19\u2014preliminary report. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2007764.", "ArticleIdList": ["10.1056/NEJMoa2007764", "PMC7262788", "32445440"]}, {"Citation": "Bosch B.J., Bartelink W., Rottier P.J. Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J. Virol. 2008;82:8887\u20138890. doi: 10.1128/JVI.00415-08.", "ArticleIdList": ["10.1128/JVI.00415-08", "PMC2519682", "18562523"]}, {"Citation": "Broughton J.P., Deng X., Yu G., Fasching C.L., Servellita V., Singh J., Miao X., Streithorst J.A., Granados A., Sotomayor-Gonzalez A., Zorn K. CRISPR\u2013Cas12-based detection of SARS-CoV-2. Nat. Biotechnol. 2020;38:870\u2013874. doi: 10.1038/s41587-020-0513-4.", "ArticleIdList": ["10.1038/s41587-020-0513-4", "PMC9107629", "32300245"]}, {"Citation": "Buonaguro F.M., Ascierto P.A., Morse G.D., Buonaguro L., Puzanov I., Tornesello M.L., Br\u00e9chot C., Gallo R.C. Covid-19: time for a paradigm change. Rev. Med. Virol. 2020;30:e2134. doi: 10.1002/rmv.2134.", "ArticleIdList": ["10.1002/rmv.2134", "PMC7361272", "32618072"]}, {"Citation": "Cai Q., Yang M., Liu D., Chen J., Shu D., Xia J., Liao X., Gu Y., Cai Q., Yang Y., Shen C. vol. 2020. Engineering; Beijing: March 2020. Experimental Treatment with Favipiravir for COVID-19: an Open-Label Control Study.", "ArticleIdList": ["10.1016/j.eng,3", "PMC7185795", "32346491"]}, {"Citation": "Calina D., Docea A.O., Petrakis D., Egorov A.M., Ishmukhametov A.A., Gabibov A.G., Shtilman M.I., Kostoff R., Carvalho F., Vinceti M., Spandidos D.A. 2020. Towards effective COVID-19 vaccines: updates, perspectives and challenges Int J. Mol. Med. 2020;46:3\u201316. doi: 10.3892/2Fijmm. 4596.", "ArticleIdList": ["10.3892/2Fijmm", "PMC7255458", "32377694"]}, {"Citation": "Cao B., Wang Y., Wen D., Liu W., Wang J., Fan G., Ruan L., Song B., Cai Y., Wei M., Li X. A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19. N. Engl. J. Med. 2020;382:1787\u20131799. doi: 10.1056/NEJMoa2001282.", "ArticleIdList": ["10.1056/NEJMoa2001282", "PMC7121492", "32187464"]}, {"Citation": "Cao X. COVID-19: immunopathology and its implications for therapy. immunopathology and its implications for therapy. Nat. Rev. Immunol. 2020;20:269\u2013270. doi: 10.1038/s41577-020-0308-3.", "ArticleIdList": ["10.1038/s41577-020-0308-3", "PMC7143200", "32273594"]}, {"Citation": "Carelli J.D., Sethofer S.G., Smith G.A., Miller H.R., Simard J.L., Merrick W.C., Jain R.K., Ross N.T., Taunton J. Ternatin and improved synthetic variants kill cancer cells by targeting the elongation factor-1A ternary complex. Elife. 2015;4:e10222. doi: 10.7554/eLife.10222.", "ArticleIdList": ["10.7554/eLife.10222", "PMC4786417", "26651998"]}, {"Citation": "Cascella M., Rajnik M., Cuomo A., Dulebohn S.C., Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19) Statpearls. 2020 https://www.ncbi.nlm.nih.gov/books/NBK554776/ [internet]", "ArticleIdList": ["32150360"]}, {"Citation": "Chamberlain L.H., Shipston M.J. The physiology of protein S-acylation. Physiol. Rev. 2015;95:341\u2013376. doi: 10.1152/physrev.00032.2014.", "ArticleIdList": ["10.1152/physrev.00032.2014", "PMC4551212", "25834228"]}, {"Citation": "Chauhan G., Madou M.J., Kalra S., Chopra V., Ghosh D., Martinez-Chapa S.O. Nanotechnology for COVID-19: therapeutics and vaccine research. ACS Nano. 2020;14:7760\u20137782. doi: 10.1021/acsnano.0c04006.", "ArticleIdList": ["10.1021/acsnano.0c04006", "32571007"]}, {"Citation": "Chen Z., Hu J., Zhang Z., Jiang S., Han S., Yan D., Zhuang R., Hu B., Zhang Z. Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. medRxiv. 2020.", "ArticleIdList": ["10.1101/2020.03.22.20040758"]}, {"Citation": "Chen J., Xia L., Liu L., Xu Q., Ling Y., Huang D., Huang W., Song S., Xu S., Shen Y., Lu H. Antiviral activity and safety of darunavir/cobicistat for the treatment of COVID-19. Open Forum Infect. Dis. 2020;7(7):ofaa241. doi: 10.1093/ofid/ofaa241.", "ArticleIdList": ["10.1093/ofid/ofaa241", "PMC7337805", "32671131"]}, {"Citation": "Chu C.M., Cheng V.C.C., Hung I.F.N., Wong M.M.L., Chan K.H., Chan K.S., Kao R.Y.T., Poon L.L.M., Wong C.L.P., Guan Y., Peiris J.S.M. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252\u2013256. doi: 10.1136/thorax.2003.012658.", "ArticleIdList": ["10.1136/thorax.2003.012658", "PMC1746980", "14985565"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W. Treatment of SARS with human interferons. Lancet. 2003;362:293\u2013294. doi: 10.1016/S0140-6736(03)13973-6.", "ArticleIdList": ["10.1016/S0140-6736(03)13973-6", "PMC7112413", "12892961"]}, {"Citation": "Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int. J. Antimicrob. Agents. 2020;55(105932) doi: 10.1016/j.ijantimicag.2020.105932.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105932", "PMC7135139", "32145363"]}, {"Citation": "Corbett K.S., Edwards D.K., Leist S.R., Abiona O.M., Boyoglu-Barnum S., Gillespie R.A., Himansu S., Sch\u00e4fer A., Ziwawo C.T., DiPiazza A.T., Dinnon K.H. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020;586:567\u2013571. https://www.nature.com/articles/s41586-020-2622-0#citeas", "ArticleIdList": ["PMC7581537", "32756549"]}, {"Citation": "Coronavirus Vaccine Tracker. The New York Times; 2020. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html [cited 2021 January 9]; Available from:"}, {"Citation": "COVID-19 therapies and vaccine landscape. Nat. Mater. 2020;809:19. doi: 10.1038/s41563-020-0758-9.", "ArticleIdList": ["10.1038/s41563-020-0758-9", "32704138"]}, {"Citation": "Dance A. COVID-19 vaccines GET biotech boost. Nature. 2020:647\u2013649. doi: 10.1038/d41586-020-02154-2.", "ArticleIdList": ["10.1038/d41586-020-02154-2", "32694847"]}, {"Citation": "De Wilde A.H., Jochmans D., Posthuma C.C., Zevenhoven-Dobbe J.C., Van Nieuwkoop S., Bestebroer T.M., Van Den Hoogen B.G., Neyts J., Snijder E.J. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob. Agents Chemother. 2014;58:4875\u20134884. doi: 10.1128/AAC.03011-14.", "ArticleIdList": ["10.1128/AAC.03011-14", "PMC4136071", "24841269"]}, {"Citation": "Draft Landscape of COVID-19 Candidate Vaccines. World Health Organization; 2020. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines [cited 2021 January 9]; Available from:"}, {"Citation": "Details - Public Health Image Library (PHIL)   2020. Public Health Image Library, Centers for Disease Control and Prevention, 2020.https://phil.cdc.gov/Details.aspx?pid=23354 [cited 2020 August 19]; Available from:"}, {"Citation": "Faivre E.J., McDaniel K.F., Albert D.H., Mantena S.R., Plotnik J.P., Wilcox D., Zhang L., Bui M.H., Sheppard G.S., Wang L., Sehgal V. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer. Nature. 2020;578:306\u2013310. doi: 10.1038/s41586-020-1930-8.", "ArticleIdList": ["10.1038/s41586-020-1930-8", "31969702"]}, {"Citation": "Falzarano D., De Wit E., Martellaro C., Callison J., Munster V.J., Feldmann H. Inhibition of novel \u03b2 coronavirus replication by a combination of interferon-\u03b12b and ribavirin. Sci. Rep. 2013;3:1\u20136. doi: 10.1038/srep01686.", "ArticleIdList": ["10.1038/srep01686", "PMC3629412", "23594967"]}, {"Citation": "Faria P.A., Chakraborty P., Levay A., Barber G.N., Ezelle H.J., Enninga J., Arana C., Van Deursen J., Fontoura B.M. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell. 2005;17:93\u2013102. doi: 10.1016/j.molcel.2004.11.023.", "ArticleIdList": ["10.1016/j.molcel.2004.11.023", "15629720"]}, {"Citation": "Folegatti P.M., Ewer K.J., Aley P.K., Angus B., Becker S., Belij-Rammerstorfer S., Bellamy D., Bibi S., Bittaye M., Clutterbuck E.A., Dold C. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396:467\u2013478. doi: 10.1016/S0140-6736(20)31604-4.", "ArticleIdList": ["10.1016/S0140-6736(20)31604-4", "PMC7445431", "32702298"]}, {"Citation": "Gagliardi S., Nadler G., Consolandi E., Parini C., Morvan M., Legave M.N., Belfiore P., Zocchetti A., Clarke G.D., James I., Nambi P. 5-(5, 6-Dichloro-2-indolyl)-2-methoxy-2, 4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity. J. Med. Chem. 1998;41:1568\u20131573. doi: 10.1021/jm9800144.", "ArticleIdList": ["10.1021/jm9800144", "9572882"]}, {"Citation": "Gao J., Hu S. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19) BioSci. Trends. 2020;14:156\u2013158. doi: 10.5582/bst.2020.03072.", "ArticleIdList": ["10.5582/bst.2020.03072", "32281583"]}, {"Citation": "Gao J., Tian Z., Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. BioSci. Trends. 2020;14:72\u201373. doi: 10.5582/bst.2020.01047.", "ArticleIdList": ["10.5582/bst.2020.01047", "32074550"]}, {"Citation": "Garcia de Abajo F.J., Hern\u00e1ndez R.J., Kaminer I., Meyerhans A., Rosell-Llompart J., Sanchez-Elsner T. Back to normal: an old physics route to reduce SARS-CoV-2 transmission in indoor spaces. ACS Nano. 2020;14:7704\u20137713. doi: 10.1021/acsnano.0c04596.", "ArticleIdList": ["10.1021/acsnano.0c04596", "32551537"]}, {"Citation": "Garcia-Cremades M., Solans B.P., Hughes E., Ernest J.P., Wallender E., Aweeka F., Luetkemeyer A.F., Savic R.M. Optimizing hydroxychloroquine dosing for patients with COVID-19: an integrative modeling approach for effective drug repurposing. Clin. Pharmacol. Ther. 2020;108:253\u2013263. doi: 10.1002/cpt.1856.", "ArticleIdList": ["10.1002/cpt.1856", "PMC7262072", "32285930"]}, {"Citation": "Gautret P., Lagier J.C., Parola P., Meddeb L., Mailhe M., Doudier B., Courjon J., Giordanengo V., Vieira V.E., Dupont H.T., Honor\u00e9 S. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents. 2020;56(105949) doi: 10.1016/j.ijantimicag.2020.105949.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105949", "PMC7102549", "32205204"]}, {"Citation": "Gibani M.M., Toumazou C., Sohbati M., Sahoo R., Karvela M., Hon T.K., De Mateo S., Burdett A., Leung K.F., Barnett J., Orbeladze A. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study. Lancet Microbe. 2020;1:300\u2013e307. doi: 10.1016/S2666-5247(20)30121-X.", "ArticleIdList": ["10.1016/S2666-5247(20)30121-X", "PMC7498257", "32964211"]}, {"Citation": "Gielen V., Johnston S.L., Edwards M.R. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur. Respir. J. 2010;36:646\u2013654. doi: 10.1183/09031936.00095809.", "ArticleIdList": ["10.1183/09031936.00095809", "20150207"]}, {"Citation": "Goldsmith C.S., Miller S.E., Martines R.B., Bullock H.A., Zaki S.R. Electron microscopy of SARS-CoV-2: a challenging task. Lancet. 2020;395:e99. doi: 10.1016/S0140-6736(20)31188-0.", "ArticleIdList": ["10.1016/S0140-6736(20)31188-0", "PMC7237172", "32442529"]}, {"Citation": "Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O'Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., Tummino T.A. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459\u2013468. doi: 10.1038/s41586-020-2286-9.", "ArticleIdList": ["10.1038/s41586-020-2286-9", "PMC7431030", "32353859"]}, {"Citation": "Gordon D., Jang G., Bouhaddou M., Xu J., Obernier K., O'Meara M., Guo J., Swaney D., Tummino T., H\u00fcttenhain R. A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv Prepr. Serv. Biol. 2020;19 doi: 10.1038/s41586-020-2286-9.", "ArticleIdList": ["10.1038/s41586-020-2286-9"]}, {"Citation": "Ha\u0142adyj E., Sikora M., Felis-Giemza A., Olesi\u0144ska M. Antimalarials\u2013are they effective and safe in rheumatic diseases? Reumatologia. 2018;56(164) doi: 10.5114/reum.2018.76904.", "ArticleIdList": ["10.5114/reum.2018.76904", "PMC6052376", "30042604"]}, {"Citation": "Haq F.U., Roman M., Ahmad K., Rahman S.U., Shah S.M.A., Suleman N., Ullah S., Ahmad I., Ullah W. Artemisia annua: trials are needed for COVID-19. Phytother Res. 2020;34:2423\u20132424. doi: 10.1002/ptr.6733.", "ArticleIdList": ["10.1002/ptr.6733", "PMC7276816", "32424845"]}, {"Citation": "Hellewell S.B., Bruce A., Feinstein G., Orringer J., Williams W., Bowen W.D. Rat liver and kidney contain high densities of \u03c31 and \u03c32 receptors: characterization by ligand binding and photoaffinity labelling. Eur. J. Pharmacol. 1994;268:9\u201318. doi: 10.1016/0922-4106(94)90115-5.", "ArticleIdList": ["10.1016/0922-4106(94)90115-5", "7925616"]}, {"Citation": "Hoffmann M., M\u00f6sbauer K., Hofmann-Winkler H., Kaul A., Kleine-Weber H., Kr\u00fcger N., Gassen N.C., M\u00fcller M.A., Drosten C., P\u00f6hlmann S. Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2. Nature. 2020;585:588\u2013590. doi: 10.1038/s41586-020-2575-3.", "ArticleIdList": ["10.1038/s41586-020-2575-3", "32698190"]}, {"Citation": "Hu T.Y., Frieman M., Wolfram J. Insights from nanomedicine into chloroquine efficacy against COVID-19. Nat. Nanotechnol. 2020;15:247\u2013249. doi: 10.1038/s41565-020-0674-9.", "ArticleIdList": ["10.1038/s41565-020-0674-9", "PMC7094976", "32203437"]}, {"Citation": "Huang M., Tang T., Pang P., Li M., Ma R., Lu J., Shu J., You Y., Chen B., Liang J., Hong Z. Treating COVID-19 with chloroquine. J. Mol. Cell Biol. 2020;12:322\u2013325. doi: 10.1093/jmcb/mjaa014.", "ArticleIdList": ["10.1093/jmcb/mjaa014", "PMC7232130", "32236562"]}, {"Citation": "Huentelman M.J., Zubcevic J., Hernandez Prada J.A., Xiao X., Dimitrov D.S., Raizada M.K., Ostrov D.A. Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. Hypertension. 2004;44:903\u2013906. doi: 10.1161/01.HYP.0000146120.29648.36.", "ArticleIdList": ["10.1161/01.HYP.0000146120.29648.36", "15492138"]}, {"Citation": "Ivanov P., Kedersha N., Anderson P. Stress granules and processing bodies in translational control. Cold Spring Harbor Perspect Biol. 11, a032813. 2019.", "ArticleIdList": ["10.1016/j.molcel.2019.09.014", "PMC6496347", "30082464"]}, {"Citation": "Kadam R.U., Wilson I.A. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc. Natl. Acad. Sci. Unit. States Am. 2017;114:206\u2013214. doi: 10.1073/pnas.1617020114.", "ArticleIdList": ["10.1073/pnas.1617020114", "PMC5240704", "28003465"]}, {"Citation": "Kandeel M., Al-Nazawi M. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sci. 2020;251(117627) doi: 10.1016/j.lfs.2020.117627.", "ArticleIdList": ["10.1016/j.lfs.2020.117627", "PMC7194560", "32251634"]}, {"Citation": "Kaniyala Melanthota S., Banik S., Chakraborty I., Pallen S., Gopal D., Chakrabarti S., Mazumder N. Elucidating the microscopic and computational techniques to study the structure and pathology of SARS-CoVs. Microsc. Res. Tech. 2020;83:1623\u20131638. doi: 10.1002/jemt.23551.", "ArticleIdList": ["10.1002/jemt.23551", "PMC7436590", "32770582"]}, {"Citation": "Kazama I., Maruyama Y., Murata Y., Sano M. Voltage-dependent biphasic effects of chloroquine on delayed rectifier K+-channel currents in murine thymocytes. J. Physiol. Sci. 2012;62:267\u2013274. doi: 10.1007/s12576-012-0195-x.", "ArticleIdList": ["10.1007/s12576-012-0195-x", "22328488"]}, {"Citation": "Khan N., Jeffers M., Kumar S., Hackett C., Boldog F., Khramtsov N., Qian X., Mills E., Berghs S.C., Carey N., Finn P.W. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem. J. 2008;409:581\u2013589. doi: 10.1042/bj20070779.", "ArticleIdList": ["10.1042/bj20070779", "17868033"]}, {"Citation": "Kim M.H., Berkowitz C., Trohman R.G. Polymorphic ventricular tachycardia with a normal QT interval following azithromycin. Pacing Clin. Electrophysiol. 2005;28:1221\u20131222. doi: 10.1111/j.1540-8159.2005.50146.x.", "ArticleIdList": ["10.1111/j.1540-8159.2005.50146.x", "16359290"]}, {"Citation": "Kindrachuk J., Ork B., Hart B.J., Mazur S., Holbrook M.R., Frieman M.B., Traynor D., Johnson R.F., Dyall J., Kuhn J.H., Olinger G.G. Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob. Agents Chemother. 2015;59:1088\u20131099. doi: 10.1128/AAC.03659-14.", "ArticleIdList": ["10.1128/AAC.03659-14", "PMC4335870", "25487801"]}, {"Citation": "Knoops K., Kikkert M., Van Den Worm S.H., Zevenhoven-Dobbe J.C., Van Der Meer Y., Koster A.J., Mommaas A.M., Snijder E.J. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008;6:e226. doi: 10.1371/journal.pbio.0060226.", "ArticleIdList": ["10.1371/journal.pbio.0060226", "PMC2535663", "18798692"]}, {"Citation": "Kondo T., Watanabe M., Hatakeyama S. TRIM59 interacts with ECSIT and negatively regulates NF-\u03baB and IRF-3/7-mediated signal pathways. Biochem. Biophys. Res. Commun. 2012;422:501\u2013507. doi: 10.1016/j.bbrc.2012.05.028.", "ArticleIdList": ["10.1016/j.bbrc.2012.05.028", "22588174"]}, {"Citation": "Konno H., Onuma T., Nitanai I., Wakabayashi M., Yano S., Teruya K., Akaji K. Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor. Bioorg. Med. Chem. 2017;27:2746\u20132751. doi: 10.1016/j.bmcl.2017.04.056.", "ArticleIdList": ["10.1016/j.bmcl.2017.04.056", "PMC7127027", "28454669"]}, {"Citation": "Kr\u00e4mer O.H., Zhu P., Ostendorff H.P., Golebiewski M., Tiefenbach J., Peters M.A., Brill B., Groner B., Bach I., Heinzel T., G\u00f6ttlicher M. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J. 2003;22:3411\u20133420. doi: 10.1093/emboj/cdg315.", "ArticleIdList": ["10.1093/emboj/cdg315", "PMC165640", "12840003"]}, {"Citation": "Kumar K., Lupoli T.J. Exploiting existing molecular scaffolds for long-term COVID treatment. ACS Med. Chem. Lett. 2020;11:1357\u20131360. doi: 10.1021/acsmedchemlett.0c00254.", "ArticleIdList": ["10.1021/acsmedchemlett.0c00254", "PMC7269097", "32665808"]}, {"Citation": "Lagier J.C., Fenollar F., Lepidi H., Giorgi R., Million M., Raoult D. Treatment of classic Whipple's disease: from in vitro results to clinical outcome. J. Antimicrob. Chemother. 2014;69:219\u2013227. doi: 10.1093/jac/dkt310.", "ArticleIdList": ["10.1093/jac/dkt310", "23946319"]}, {"Citation": "Lammers T., Sofias A.M., van der Meel R., Schiffelers R., Storm G., Tacke F., Koschmieder S., Br\u00fcmmendorf T.H., Kiessling F., Metselaar J.M. Dexamethasone.nanomedicines for COVID-19. Nat. Nanotechnol. 2020;15:622\u2013624. doi: 10.1038/s41565-020-0752-z.", "ArticleIdList": ["10.1038/s41565-020-0752-z", "PMC7116110", "32747742"]}, {"Citation": "Li S., Wang L., Berman M., Kong Y.Y., Dorf M.E. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011;35:426\u2013440. doi: 10.1016/j.immuni.2011.06.014.", "ArticleIdList": ["10.1016/j.immuni.2011.06.014", "PMC3253658", "21903422"]}, {"Citation": "Li Y., Zhang J., Wang N., Li H., Shi Y., Guo G., Liu K., Zeng H., Zou Q. Therapeutic drugs targeting 2019-nCoV main protease by high-throughput screening. BioRxiv. 2020.", "ArticleIdList": ["10.1101/2020.01.28.922922"]}, {"Citation": "Lim J., Jeon S., Shin H.Y., Kim M.J., Seong Y.M., Lee W.J., Choe K.W., Kang Y.M., Lee B., Park S.J. Case of the index patient who caused tertiary transmission of COVID-19 infection in korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. J. Kor. Med. Sci. 2020;35 doi: 10.3346/jkms.2020.35.e79. e79\u2013e79.", "ArticleIdList": ["10.3346/jkms.2020.35.e79", "PMC7025910", "32056407"]}, {"Citation": "Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., Li Y., Hu Z., Zhong W., Wang M. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:1\u20134. doi: 10.1038/s41421-020-0156-0.", "ArticleIdList": ["10.1038/s41421-020-0156-0", "PMC7078228", "32194981"]}, {"Citation": "Loutfy M.R., Blatt L.M., Siminovitch K.A., Ward S., Wolff B., Lho H., Pham D.H., Deif H., LaMere E.A., Chang M., Kain K.C. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. J. Am. Med. Assoc. 2003;290:3222\u20133228. doi: 10.1001/jama.290.24.3222.", "ArticleIdList": ["10.1001/jama.290.24.3222", "14693875"]}, {"Citation": "Maerz L.L., Akhtar S. Perioperative glycemic management in 2011: paradigm shifts. Curr. Opin. Crit. Care. 2011;17:370\u2013375. doi: 10.1097/mcc.0b013e328348beb7.", "ArticleIdList": ["10.1097/mcc.0b013e328348beb7", "21734491"]}, {"Citation": "Maisonnasse P., Guedj J., Contreras V., Behillil S., Solas C., Marlin R., Naninck T., Pizzorno A., Lemaitre J., Gon\u00e7alves A., Kahlaoui N. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates. Nature. 2020;585:584\u2013587. doi: 10.1038/s41586-020-2558-4.", "ArticleIdList": ["10.1038/s41586-020-2558-4", "32698191"]}, {"Citation": "McCallum M., Walls A.C., Bowen J.E., Corti D., Veesler D. Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation. Nat. Struct. Mol. Biol. 2020;27:942\u2013949. doi: 10.1038/s41594-020-0483-8.", "ArticleIdList": ["10.1038/s41594-020-0483-8", "PMC7541350", "32753755"]}, {"Citation": "McKee D.L., Sternberg A., Stange U., Laufer S., Naujokat C. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol. Res. 2020;157(104859) doi: 10.1016/j.phrs.2020.104859.", "ArticleIdList": ["10.1016/j.phrs.2020.104859", "PMC7189851", "32360480"]}, {"Citation": "McKee E.E., Ferguson M., Bentley A.T., Marks T.A. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob. Agents Chemother. 2006;50:2042\u20132049. doi: 10.1128/AAC.01411-05.", "ArticleIdList": ["10.1128/AAC.01411-05", "PMC1479116", "16723564"]}, {"Citation": "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) World Health Organization; 2020. https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) [cited 2020 July 20]; Available from:"}, {"Citation": "Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20131034. doi: 10.1016/S0140-6736(20)30628-0.", "ArticleIdList": ["10.1016/S0140-6736(20)30628-0", "PMC7270045", "32192578"]}, {"Citation": "Mielech A.M., Kilianski A., Baez-Santos Y.M., Mesecar A.D., Baker S.C. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology. 2014;450:64\u201370. doi: 10.1016/j.virol.2013.11.040.", "ArticleIdList": ["10.1016/j.virol.2013.11.040", "PMC3957432", "24503068"]}, {"Citation": "Miller S.E., Mathiasen S., Bright N.A., Pierre F., Kelly B.T., Kladt N., Schauss A., Merrifield C.J., Stamou D., H\u00f6ning S., Owen D.J. CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature. Dev. Cell. 2015;33:163\u2013175. doi: 10.1016/j.devcel.2015.03.002.", "ArticleIdList": ["10.1016/j.devcel.2015.03.002", "PMC4406947", "25898166"]}, {"Citation": "Mingo R.M., Simmons J.A., Shoemaker C.J., Nelson E.A., Schornberg K.L., D'Souza R.S., Casanova J.E., White J.M. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. J. Virol. 2015;89:2931\u20132943. doi: 10.1128/JVI.03398-14.", "ArticleIdList": ["10.1128/JVI.03398-14", "PMC4325712", "25552710"]}, {"Citation": "Mitsuda T., Omi T., Tanimukai H., Sakagami Y., Tagami S., Okochi M., Kudo T., Takeda M. Sigma-1Rs are upregulated via PERK/eIF2\u03b1/ATF4 pathway and execute protective function in ER stress. Biochem. Biophys. Res. Commun. 2011;415:519\u2013525. doi: 10.1016/j.bbrc.2011.10.113.", "ArticleIdList": ["10.1016/j.bbrc.2011.10.113", "22079628"]}, {"Citation": "Morgan N.D., Patel S.V., Dvorkina O. Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus. J. Clin. Rheumatol. 2013;19:286\u2013288. doi: 10.1097/rhu.0b013e31829d5e50.", "ArticleIdList": ["10.1097/rhu.0b013e31829d5e50", "23872551"]}, {"Citation": "Mosholder A.D., Mathew J., Alexander J.J., Smith H., Nambiar S. Cardiovascular risks with azithromycin and other antibacterial drugs. N. Engl. J. Med. 2013;368:1665\u20131668. doi: 10.1001/jamanetworkopen.2020.8199.", "ArticleIdList": ["10.1001/jamanetworkopen.2020.8199", "23635046"]}, {"Citation": "M\u00fcller C., Schulte F.W., Lange-Gr\u00fcnweller K., Obermann W., Madhugiri R., Pleschka S., Ziebuhr J., Hartmann R.K., Gr\u00fcnweller A. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona-and picornaviruses. Antivir. Res. 2018;150:123\u2013129. doi: 10.1016/j.antiviral.2017.12.010.", "ArticleIdList": ["10.1016/j.antiviral.2017.12.010", "PMC7113723", "29258862"]}, {"Citation": "Munster T., Gibbs J.P., Shen D., Baethge B.A., Botstein G.R., Caldwell J., Dietz F., Ettlinger R., Golden H.E., Lindsley H., McLaughlin G.E. Hydroxychloroquine concentration\u2013response relationships in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46:1460\u20131469. doi: 10.1002/art.10307.", "ArticleIdList": ["10.1002/art.10307", "12115175"]}, {"Citation": "Oestereich L., L\u00fcdtke A., Wurr S., Rieger T., Mu\u00f1oz-Fontela C., G\u00fcnther S. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antivir. Res. 2014;105:17\u201321. doi: 10.1016/j.antiviral.2014.02.014.", "ArticleIdList": ["10.1016/j.antiviral.2014.02.014", "24583123"]}, {"Citation": "Oliver M.E., Hinks T.S. Azithromycin in viral infections. Rev. Med. Virol. 2020:e2163. doi: 10.1002/rmv.2163.", "ArticleIdList": ["10.1002/rmv.2163", "PMC7536932", "32969125"]}, {"Citation": "Park J.Y., Yuk H.J., Ryu H.W., Lim S.H., Kim K.S., Park K.H., Ryu Y.B., Lee W.S. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzym. Inhib. Med. Chem. 2017;32:504\u2013512. doi: 10.1080/14756366.2016.1265519.", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Pierre F., Chua P.C., O'Brien S.E., Siddiqui-Jain A., Bourbon P., Haddach M., Michaux J., Nagasawa J., Schwaebe M.K., Stefan E., Vialettes A. Discovery and SAR of 5-(3-chlorophenylamino) benzo [c][2, 6] naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer. J. Med. Chem. 2011;54:635\u2013654. doi: 10.1021/jm101251q.", "ArticleIdList": ["10.1021/jm101251q", "21174434"]}, {"Citation": "Pillaiyar T., Meenakshisundaram S., Manickam M. Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov. Today. 2020;25:668\u2013688. doi: 10.1016/j.drudis.2020.01.015.", "ArticleIdList": ["10.1016/j.drudis.2020.01.015", "PMC7102522", "32006468"]}, {"Citation": "Raaben M., Groot Koerkamp M.J., Rottier P.J., De Haan C.A. Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies. Cell Microbiol. 2007;9:2218\u20132229. doi: 10.1111/j.1462-5822.2007.00951.x.", "ArticleIdList": ["10.1111/j.1462-5822.2007.00951.x", "PMC7162177", "17490409"]}, {"Citation": "Rabi F.A., Al Zoubi M.S., Kasasbeh G.A., Salameh D.M., Al-Nasser A.D. SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens. 2020;9(231) doi: 10.3390/pathogens9030231.", "ArticleIdList": ["10.3390/pathogens9030231", "PMC7157541", "32245083"]}, {"Citation": "Reineke L.C., Tsai W.C., Jain A., Kaelber J.T., Jung S.Y., Lloyd R.E. Casein kinase 2 is linked to stress granule dynamics through phosphorylation of the stress granule nucleating protein G3BP1. Mol. Cell Biol. 2017;37 doi: 10.1128/MCB.00596-16. e00596\u201316.", "ArticleIdList": ["10.1128/MCB.00596-16", "PMC5288577", "27920254"]}, {"Citation": "Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs. N. Engl. J. Med. 2005;353:1711\u20131723. doi: 10.1056/NEJMra050541.", "ArticleIdList": ["10.1056/NEJMra050541", "16236742"]}, {"Citation": "Roden D.M., Harrington R.A., Poppas A., Russo A.M. Considerations for drug interactions on QTc in exploratory COVID-19 treatment. Circulation. 2020;141:e906\u2013e907. doi: 10.1161/CIRCULATIONAHA.120.047521.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.120.047521", "32267732"]}, {"Citation": "Rodr\u00edguez-Menchaca A.A., Navarro-Polanco R.A., Ferrer-Villada T., Rupp J., Sachse F.B., Tristani-Firouzi M., S\u00e1nchez-Chapula J.A. The molecular basis of chloroquine block of the inward rectifier Kir2. 1 channel. Proc. Natl. Acad. Sci. Unit. States Am. 2008;105:1364\u20131368. doi: 10.1073/pnas.0708153105.", "ArticleIdList": ["10.1073/pnas.0708153105", "PMC2234144", "18216262"]}, {"Citation": "Ryzhakov G., Randow F. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 2007;26:3180\u20133190. doi: 10.1038/sj.emboj.7601743.", "ArticleIdList": ["10.1038/sj.emboj.7601743", "PMC1914091", "17568778"]}, {"Citation": "Sadegh S., Matschinske J., Blumenthal D.B., Galindez G., Kacprowski T., List M., Nasirigerdeh R., Oubounyt M., Pichlmair A., Rose T.D., Salgado-Albarr\u00e1n M. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing. Nat. Commun. 2020;11:1\u20139. doi: 10.1038/s41467-020-17189-2.", "ArticleIdList": ["10.1038/s41467-020-17189-2", "PMC7360763", "32665542"]}, {"Citation": "Santos J.R., Curran A., Navarro-Mercade J., Ampuero M.F., Pelaez P., P\u00e9rez-Alvarez N., Clotet B., Paredes R., Molt\u00f3 J. Simplification of antiretroviral treatment from darunavir/ritonavir monotherapy to darunavir/cobicistat monotherapy: effectiveness and safety in routine clinical practice. AIDS Res. Hum. Retrovir. 2019;35:513\u2013518. doi: 10.1089/aid.2018.0178.", "ArticleIdList": ["10.1089/aid.2018.0178", "30909716"]}, {"Citation": "Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., Deng Y., Wang H., Ye F., Cen S., Tan W. High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J. Virol. 2019;93:8017\u20138028. doi: 10.1128/JVI.00023-19.", "ArticleIdList": ["10.1128/JVI.00023-19", "PMC6613765", "30918074"]}, {"Citation": "Shereen M.A., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91\u201398. doi: 10.1016/j.jare.2020.03.005Get.", "ArticleIdList": ["10.1016/j.jare.2020.03.005Get", "PMC7113610", "32257431"]}, {"Citation": "Shigdel U.K., Lee S.J., Sowa M.E., Bowman B.R., Robison K., Zhou M., Pua K.H., Stiles D.T., Blodgett J.A., Udwary D.W., Rajczewski A.T. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface. Proc. Natl. Acad. Sci. Unit. States Am. 2020;117:17195\u201317203. doi: 10.1073/pnas.2006560117.", "ArticleIdList": ["10.1073/pnas.2006560117", "PMC7382241", "32606248"]}, {"Citation": "Shimamoto Y., Hattori Y., Kobayashi K., Teruya K., Sanjoh A., Nakagawa A., Yamashita E., Akaji K. Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors. Bioorg. Med. Chem. 2015;23:876\u2013890. doi: 10.1016/j.bmc.2014.12.028.", "ArticleIdList": ["10.1016/j.bmc.2014.12.028", "PMC7111320", "25614110"]}, {"Citation": "Shin J.S., Jung E., Kim M., Baric R.S., Go Y.Y. Saracatinib inhibits middle east respiratory syndrome-coronavirus replication in vitro. Viruses. 2018;10(283) doi: 10.3390/v10060283.", "ArticleIdList": ["10.3390/v10060283", "PMC6024778", "29795047"]}, {"Citation": "Shin M.D., Shukla S., Chung Y.H., Beiss V., Chan S.K., Ortega-Rivera O.A., Wirth D.M., Chen A., Sack M., Pokorski J.K., Steinmetz N.F. COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol. 2020;15:646\u2013655. doi: 10.1038/s41565-020-0737-y.", "ArticleIdList": ["10.1038/s41565-020-0737-y", "32669664"]}, {"Citation": "Sintchak M.D., Nimmesgern E. The structure of inosine 5\u2032-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology. 2000;47:163\u2013184. doi: 10.1016/S0162-3109(00)00193-4.", "ArticleIdList": ["10.1016/S0162-3109(00)00193-4", "10878288"]}, {"Citation": "\u201cSolidarity\u201d Clinical Trial for COVID-19 Treatments. World Health Organization; 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments [cited 2020 September 4]; Available from:"}, {"Citation": "Soucy T.A., Smith P.G., Milhollen M.A., Berger A.J., Gavin J.M., Adhikari S., Brownell J.E., Burke K.E., Cardin D.P., Critchley S., Cullis C.A. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458:732\u2013736. doi: 10.1038/nature07884.", "ArticleIdList": ["10.1038/nature07884", "19360080"]}, {"Citation": "Statement on the second meeting of the International Health Regulations . World Health Organization; 2005. Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) 2020. [cited 2020 September 3]; Available from:"}, {"Citation": "Tang Y., Liu J., Zhang D., Xu Z., Ji J., Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front. Immunol. 2020;11(1708) doi: 10.3389/fimmu.2020.01708.", "ArticleIdList": ["10.3389/fimmu.2020.01708", "PMC7365923", "32754163"]}, {"Citation": "Teissier E., Zandomeneghi G., Loquet A., Lavillette D., Lavergne J.P., Montserret R., Cosset F.L., B\u00f6ckmann A., Meier B.H., Penin F., P\u00e9cheur E.I. Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol. PloS One. 2011;6:e15874. doi: 10.1371/journal.pone.0015874.", "ArticleIdList": ["10.1371/journal.pone.0015874", "PMC3026800", "21283579"]}, {"Citation": "Tisdale J.E., Jaynes H.A., Kingery J.R., Mourad N.A., Trujillo T.N., Overholser B.R., Kovacs R.J. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ. Cardiovasc. Qual. Outcomes. 2013;6:479\u2013487. doi: 10.1161/circoutcomes.113.000152.", "ArticleIdList": ["10.1161/circoutcomes.113.000152", "PMC3788679", "23716032"]}, {"Citation": "Tyteca D., Van Der Smissen P., Mettlen M., Van Bambeke F., Tulkens P.M., Mingeot-Leclercq M.P., Courtoy P.J. Azithromycin, a lysosomotropic antibiotic, has distinct effects on fluid-phase and receptor-mediated endocytosis, but does not impair phagocytosis in J774 macrophages. Exp. Cell Res. 2002;281:86\u2013100. doi: 10.1006/excr.2002.5613.", "ArticleIdList": ["10.1006/excr.2002.5613", "12441132"]}, {"Citation": "ul Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 2020;10:313\u2013319. doi: 10.1016/j.jpha.2020.03.009.", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Ursing J., Rombo L., Eksborg S., Larson L., Bruvoll A., Tarning J., Rodrigues A., Kofoed P.E. High-dose chloroquine for uncomplicated plasmodium falciparum malaria is well tolerated and causes similar QT interval prolongation as standard-dose chloroquine in children. Antimicrob. Agents Chemother. 2020;64 doi: 10.1128/aac.01846-19. e01846\u201319.", "ArticleIdList": ["10.1128/aac.01846-19", "PMC7038251", "31907183"]}, {"Citation": "van Riel D., de Wit E. Next-generation vaccine platforms for COVID-19. Nat. Mater. 2020;19:810\u2013812. doi: 10.1038/s41563-020-0746-0.", "ArticleIdList": ["10.1038/s41563-020-0746-0", "32704139"]}, {"Citation": "Vashist S.K. In vitro diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics. 2020;10(202) doi: 10.3390/diagnostics10040202.", "ArticleIdList": ["10.3390/diagnostics10040202", "PMC7235801", "32260471"]}, {"Citation": "Villar J., Ferrando C., Mart\u00ednez D., Ambr\u00f3s A., Mu\u00f1oz T., Soler J.A., Aguilar G., Alba F., Gonz\u00e1lez-Higueras E., Conesa L.A., Mart\u00edn-Rodr\u00edguez C. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir. Med. 2020;8:267\u2013276. doi: 10.1016/S2213-2600(19)30417-5.", "ArticleIdList": ["10.1016/S2213-2600(19)30417-5", "32043986"]}, {"Citation": "Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G., Seidah N.G., Nichol S.T. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol. J. 2005;2:1\u201310. doi: 10.1186/1743-422X-2-69.", "ArticleIdList": ["10.1186/1743-422X-2-69", "PMC1232869", "16115318"]}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269\u2013271. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization; 2020. https://covid19.who.int [cited 2021 January 9]; Available from:"}, {"Citation": "Wilson L., Gage P., Ewart G. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication. Virology. 2006;353:294\u2013306. doi: 10.1016/j.virol.2006.05.028.", "ArticleIdList": ["10.1016/j.virol.2006.05.028", "PMC7111787", "16815524"]}, {"Citation": "Wolfram J., Nizzero S., Liu H., Li F., Zhang G., Li Z., Shen H., Blanco E., Ferrari M. A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery. Sci. Rep. 2017;7(1):1\u201313. doi: 10.1038/s41598-017-14221-2.", "ArticleIdList": ["10.1038/s41598-017-14221-2", "PMC5653759", "29062065"]}, {"Citation": "Wrobel A.G., Benton D.J., Xu P., Roustan C., Martin S.R., Rosenthal P.B., Skehel J.J., Gamblin S.J. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat. Struct. Mol. Biol. 2020;27:763\u2013767. doi: 10.1038/s41594-020-0468-7.", "ArticleIdList": ["10.1038/s41594-020-0468-7", "PMC7610980", "32647346"]}, {"Citation": "Xia X., Cui J., Wang H.Y., Zhu L., Matsueda S., Wang Q., Yang X., Hong J., Songyang Z., Chen Z.J., Wang R.F. NLRX1 negatively regulates TLR-induced NF-\u03baB signaling by targeting TRAF6 and IKK. Immunity. 2011;34:843\u2013853. doi: 10.1016/j.immuni.2011.02.022.", "ArticleIdList": ["10.1016/j.immuni.2011.02.022", "PMC3150212", "21703539"]}, {"Citation": "Xu P., Ye S., Li K., Huang M., Wang Q., Zeng S., Chen X., Gao W., Chen J., Zhang Q., Zhong Z. NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2. J. Exp. Clin. Canc. Res. 2019;38:1\u201316. doi: 10.1186/s13046-019-1448-9.", "ArticleIdList": ["10.1186/s13046-019-1448-9", "PMC6896289", "31805977"]}, {"Citation": "Yang Z.Y., Huang Y., Ganesh L., Leung K., Kong W.P., Schwartz O., Subbarao K., Nabel G.J. pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J. Virol. 2004;78:5642\u20135650. doi: 10.1128/JVI.78.11.5642-5650.2004.", "ArticleIdList": ["10.1128/JVI.78.11.5642-5650.2004", "PMC415834", "15140961"]}, {"Citation": "Zhang M., Xie M., Li S., Gao Y., Xue S., Huang H., Chen K., Liu F., Chen L. Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin. Cardiovasc. Toxicol. 2017;17:434\u2013440. doi: 10.1007/s12012-017-9401-7.", "ArticleIdList": ["10.1007/s12012-017-9401-7", "28213753"]}, {"Citation": "Zhou D., Dai S.M., Tong Q. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J. Antimicrob. Chemother. 2020;75:1667\u20131670. doi: 10.1093/jac/dkaa114.", "ArticleIdList": ["10.1093/jac/dkaa114", "PMC7184499", "32196083"]}, {"Citation": "Zhu N., Wang W., Liu Z., Liang C., Wang W., Ye F., Huang B., Zhao L., Wang H., Zhou W., Deng Y. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat. Commun. 2020;11:1\u20138. doi: 10.1038/s41467-020-17796-z.", "ArticleIdList": ["10.1038/s41467-020-17796-z", "PMC7413383", "32764693"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/nejmoa2001017.", "ArticleIdList": ["10.1056/nejmoa2001017", "PMC7092803", "31978945"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "11"}, {"Year": "2021", "Month": "2", "Day": "6"}, {"Year": "2021", "Month": "2", "Day": "19"}, {"Year": "2021", "Month": "2", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "27", "Hour": "20", "Minute": "8"}, {"Year": "2021", "Month": "2", "Day": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33639193", "PMC7905377", "10.1016/j.ejphar.2021.173977", "S0014-2999(21)00130-8"]}}], "PubmedBookArticle": []}